col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Federal Scientific Center for Medical and Preventive Health Risk Management Technologies

51 Results       Page 1

 [1] 
  original article Journal Date Title Authors Max. 6 Authors
1 [GO] Health Risk Analysis 2023―Oct―17 Subjective assessment of occupational risk factors for health and psychoemotional state of health care workers under changed working conditions during the COVID-19 pandemic K.A. Hutsich, G.E. Kosiachenko, S.I. Sychik, Е.A. Nikalayeva, I.V. Madeksha
2 [GO] Health Risk Analysis 2023―Oct―16 SUBJECTIVE ASSESSMENT OF OCCUPATIONAL RISK FACTORS FOR HEALTH AND PSYCHOEMOTIONAL STATE OF HEALTH CARE WORKERS UNDER CHANGED WORKING CONDITIONS DURING THE COVID-19 PANDEMIC K.A. Hutsich, G.E. Kosiachenko, S.I. Sychik, E.A. Nikalayeva, I.V. Madeksha
3 [GO] Health Risk Analysis 2023―Jul―12 Spatial-dynamic heterogeneity of the COVID-19 epidemic process in the Russian Federation regions (2020-2023) N.V. Zaitseva, S.V. Kleyn, M.V. Glukhikh
4 [GO] Health Risk Analysis 2023―Jul―12 Predicting risks of prothrombotic readiness under COVID-19 using genetic testing N.A. Vorobyeva, A.I. Vorobyeva, A.S. Vorontsova
5 [GO] Health Risk Analysis 2023―May―25 Hygienic aspects of anti COVID-19 measures T.S. Isiutina-Fedotkova, Y.V. Zhernov, V.V. Makarova, D.V. Shcherbakov, N.N. Zabroda, N.A. Ermakova, V.A. Sukhov, A.A. Klimova, D.A. Kraskevich
6 [GO] Health Risk Analysis 2023―May―25 The risk of developing severe clinical forms of covid-19 in healthcare workers in the initial period of the pandemic: Non-occupational factors and laboratory prognostic indicators T.A. Platonova, A.A. Golubkova, M.S. Sklyar, E.A. Karbovnichaya, S.S. Smirnova, K.V. Varchenko, A.A. Ivanova, A.B. Komissarov, D.A. Lioznov
7 [GO] Health Risk Analysis 2023―May―22 Hygienic aspects of anti COVID-19 measures T.S. Isiutina-Fedotkova, Y.V. Zhernov, V.V. Makarova, D.V. Shcherbakov, N.N. Zabroda, N.A. Ermakova, V.A. Sukhov, A.A. Klimova, D.A. Kraskevich
8 [GO] Health Risk Analysis 2023―May―22 The risk of developing severe clinical forms of covid-19 in healthcare workers in the initial period of the pandemic: Non-occupational factors and laboratory prognostic indicators T.A. Platonova, A.A. Golubkova, M.S. Sklyar, E.A. Karbovnichaya, S.S Smirnova, K.V. Varchenko, A.A. Ivanova, A.B. Komissarov, D.A. Lioznov
9 [GO] Health Risk Analysis 2023―Mar―13 Immune status and cytokine spectrum as predictors of the risk of severe disease and performance indicators of intensive therapy in patients with coronavirus infection COVID-19 V.F. Sadykov, R.A. Poltavtseva, A.V. Chaplygina, N.V. Bobkova
10 [GO] Health Risk Analysis 2023―Jan―12 Immune status and cytokine spectrum as predictors of the risk of severe disease and performance indicators of intensive therapy in patients with coronavirus infection covid-19 V.F. Sadykov, R.A. Poltavtseva, A.V. Chaplygina, N.V. Bobkova
11 [GO] Health Risk Analysis 2022―Oct―18 Problematic internet use as youth’s risky behavior under distance learning during the Covid-19 pandemic V.R. Kuchma, A.Yu. Makarova, E.V. Naryshkina, N.L. Yamschikova, A.Yu. Brazhnikov, A.A. Fedorinin, E.D. Laponova, N.N. Demina
12 [GO] Health Risk Analysis 2022―Oct―17 Problematic internet use as youth’s risky behavior under distance learning during the Covid-19 pandemic V.R. Kuchma, A.Yu. Makarova, E.V. Naryshkina, N.L. Yamschikova, A.Yu. Brazhnikov, A.A. Fedorinin, E.D. Laponova, N.N. Demina
13 [GO] Health Risk Analysis 2022―Oct―17 Assessment of bacterial filtration and air permeability of face masks used by people duirng the COVID-19 pandemic E.A. Shashina, E.V. Belova, O.A. Gruzdeva, A.Y. Skopin, S.V. Andreev, Y.V. Zhernov, A.V. Zhukova, T.S. Isiutina-Fedotkova, V.V. Makarova, O.V. Mitrokhin
14 [GO] Health Risk Analysis 2022―Oct―17 Young students’ lifestyle as a health risk factor during the COVID-19 pandemic under various anti-epidemic strategies A.I. Shpakou, L.G. Klimatckaia, Yu.Yu. Bocharova, A.A. Dyachuk, O.Yu. Shik
15 [GO] Health Risk Analysis 2022―Oct―17 Young students’ lifestyle as a health risk factor during the COVID-19 pandemic under various anti-epidemic strategies A.I. Shpakou, L.G. Klimatckaia, Yu.Yu. Bocharova, A.A. Dyachuk, O.Yu. Shik
16 [GO] Health Risk Analysis 2022―Oct―17 Risks of becoming infected with SARS-CoV-2 for medical personnel in a large industrial city during the pandemic: comparative assessment S.S. Smirnova, I.А. Egorov, N.N. Zhuikov, L.G. Vyatkina, А.N. Kharitonov, А.V. Semenov, О.V. Morova
17 [GO] Health Risk Analysis 2022―Oct―17 Risks of becoming infected with SARS-CoV-2 for medical personnel in a large industrial city during the pandemic: comparative assessment S.S. Smirnova, I.А. Egorov, N.N. Zhuikov, L.G. Vyatkina, А.N. Kharitonov, А.V. Semenov, О.V. Morova
18 [GO] Health Risk Analysis 2022―Jun―27 Epidemiologic aspects in prevention of the new coronavirus infection (COVID-19) (Literature review) T.M. Butaev, A.S. Tsirikhova, D.V. Kabaloeva, D.O. Kudukhova
19 [GO] Health Risk Analysis 2022―Jun―27 Assessment of bacterial filtration and air permeability of face masks used by people duirng the COVID-19 pandemic E.A. Shashina, E.V. Belova, O.A. Gruzdeva, A.Y. Skopin, S.V. Andreev, Y.V. Zhernov, A.V. Zhukova, T.S. Isiutina-Fedotkova, V.V. Makarova, O.V. Mitrokhin
20 [GO] Health Risk Analysis 2022―Jan―19 On revealing risk groups regarding emotional burn-out syndrome among medical workers during the covid-19 pandemic T.A. Platonova, A.A. Golubkova, S.S. Smirnova, E.V. Dyachenko, K.V. Shahova, A.D. Nikitskaya
21 [GO] Health Risk Analysis 2022―Jan―19 Questioning the early events leading to the COVID-19 pandemic J. Reis, R. Frutos, A. Buguet, A. Le Faou, G. Sandner, G.C. Román, P.S. Spencer
22 [GO] Health Risk Analysis 2022―Jan―19 SCORE ESTIMATE OF COVID-19 RISKS AS PER SOCIO-HYGIENIC AND BEHAVIORAL INDICATORS T.S. Isiutina-Fedotkova, D.Yu. Kazieva, V.A. Sukhov, O.V. Mitrokhin
23 [GO] Health Risk Analysis 2022―Jan―14 On revealing risk groups regarding emotional burn-out syndrome among medical workers during the covid-19 pandemic T.A. Platonova, A.A. Golubkova, S.S. Smirnova, E.V. Dyachenko, K.V. Shahova, A.D. Nikitskaya
24 [GO] Health Risk Analysis 2022―Jan―14 Questioning the early events leading to the COVID-19 pandemic J. Reis, R. Frutos, A. Buguet, A. Le Faou, G. Sandner, G.C. Román, P.S. Spence
25 [GO] Health Risk Analysis 2022―Jan―14 Score estimate of covid-19 risks as per socio-hygienic and behavioral indicators T.S. Isiutina-Fedotkova, D.Yu. Kazieva, V.A. Sukhov, O.V. Mitrokhin
26 [GO] Health Risk Analysis 2021―Oct―19 EPIDEMIOLOGIC ASPECTS IN PREVENTION OF THE NEW CORONAVIRUS INFECTION (COVID-19): LITERATURE REVIEW T.M. Butaev, A.S. Tsirikhova, D.V. Kabaloeva, D.O. Kudukhova
27 [GO] Health Risk Analysis 2021―Oct―19 ON ESTIMATING THE ADDITIONAL INCIDENCE OF COVID-19 AMONG POPULATIONS EXPOSED TO POLLUTED AMBIENT AIR: METHODICAL APPROACHES AND SOME PRACTICAL RESULTS N.V. Zaitseva, I.V. May, J. Reis, P.S. Spenser, D.A. Kiryanov, M.R. Kamaltdinov
28 [GO] Health Risk Analysis 2021―Oct―19 ADHERENCE TO VACCINATION AND PERCEPTION OF COVID-19 RISK AMONG POPULAITON IN THE REPUBLIC OF BELARUS E.A. Hutsich, S.I. Sychyk, S.L. Itpayeva-Liudchyk
29 [GO] Health Risk Analysis 2021―Oct―19 THE RISK OF COVID-19 SEVERITY IN PATIENTS WITH MS APPEARS TO BE ASSOCIATED WITH IMMUNOTHERAPY E. Iacobaeus, I. Boström, Ch. Zhukovsky, Sh.G. Berntsson, A.-M. Landtblom
30 [GO] Health Risk Analysis 2021―Oct―18 EPIDEMIOLOGIC ASPECTS IN PREVENTION OF THE NEW CORONAVIRUS INFECTION (COVID-19): LITERATURE REVIEW T.M. Butaev, A.S. Tsirikhova, D.V. Kabaloeva, D.O. Kudukhova
31 [GO] Health Risk Analysis 2021―Oct―18 ON ESTIMATING THE ADDITIONAL INCIDENCE OF COVID-19 AMONG POPULATIONS EXPOSED TO POLLUTED AMBIENT AIR: METHODICAL APPROACHES AND SOME PRACTICAL RESULTS N.V. Zaitseva, I.V. May, J. Reis, P.S. Spenser, D.A. Kiryanov, M.R. Kamaltdinov
32 [GO] Health Risk Analysis 2021―Oct―18 ADHERENCE TO VACCINATION AND PERCEPTION OF COVID-19 RISK AMONG POPULAITON IN THE REPUBLIC OF BELARUS E.A. Hutsich, S.I. Sychyk, S.L. Itpayeva-Liudchyk
33 [GO] Health Risk Analysis 2021―Oct―18 THE RISK OF COVID-19 SEVERITY IN PATIENTS WITH MS APPEARS TO BE ASSOCIATED WITH IMMUNOTHERAPY E. Iacobaeus, I. Boström, Ch. Zhukovsky, Sh.G. Berntsson, A.-M. Landtblom
34 [GO] Health Risk Analysis 2021―Jul―30 Suicides during the COVID-19 pandemic: comparing frequencies in three population groups, 9.2 million people overall V.A. Rozanov, N.V. Semenova, Yu.G. Kamenshchikov, A.Ya. Vuks, V.V. Freize, L.V. Malyshko, S.E. Zakharov, A.Yu. Kamenshchikov, V.D. Isakov, G.F. Krivda, O.D. Yagmurov, N.G. Neznanov
35 [GO] Health Risk Analysis 2021―Jul―30 COVID-19: neurological sequelae P.S. Spencer, G. Román, A. Buguet, A. Guekht, J. Reis
36 [GO] Health Risk Analysis 2021―Jul―29 Suicides during the COVID-19 pandemic: comparing frequencies in three population groups, 9.2 million people overall V.A. Rozanov, N.V. Semenova, Yu.G. Kamenshchikov, A.Ya. Vuks, V.V. Freize, L.V. Malyshko, S.E. Zakharov, A.Yu. Kamenshchikov, V.D. Isakov, G.F. Krivda, O.D. Yagmurov, N.G. Neznanov
37 [GO] Health Risk Analysis 2021―Jul―29 COVID-19: neurological sequelae P.S. Spencer, G. Román, A. Buguet, A. Guekht, J. Reis
38 [GO] Health Risk Analysis 2021―May―03 Spatio-temporal modeling of COVID-19 epidemic V.L. Sokolovsky, G.B. Furman, D.A. Polyanskaya, E.G. Furman
39 [GO] Health Risk Analysis 2021―May―03 Approaches to analyzing efficiency of respiratory protective equipment as a way to reduce health risks during COVID-19 pandemic E.A. Shashina, T.S. Isiutina-Fedotkova, V.V. Makarova, O.A. Gruzdeva, O.V. Mitrokhin
40 [GO] Health Risk Analysis 2021―Apr―09 Spatio-temporal modeling of COVID-19 epidemic V.L. Sokolovsky, G.B. Furman, D.A. Polyanskaya, E.G. Furman
41 [GO] Health Risk Analysis 2021―Apr―09 Approaches to analyzing efficiency of respiratory protective equipment as a way to reduce health risks during COVID-19 pandemic E.A. Shashina, T.S. Isiutina-Fedotkova, V.V. Makarova, O.A. Gruzdeva, O.V. Mitrokhin
42 [GO] Health Risk Analysis 2021―Jan―08 Prevalence of behavioral risk factors that cause contagion with COVID-19 among population in belarus: results obtained via cross-sectional study S.I. Sychik
43 [GO] Health Risk Analysis 2021―Jan―08 COVID-19: well-known drugs, new opportunities A.Kh. Ashirmetov, I.R. Mavlyanov, Z.I. Mavlyanov, G.Zh. Zharylkasynova
44 [GO] Health Risk Analysis 2021―Jan―08 Dependence between mortality in regions and prevalence of active SARS-COV2 carriers and resources available to public healthcare organizations V.S. Stepanov
45 [GO] Health Risk Analysis 2021―Jan―05 Prevalence of behavioral risk factors that cause contagion with COVID-19 among population in belarus: results obtained via cross-sectional study S.I. Sychik
46 [GO] Health Risk Analysis 2021―Jan―05 COVID-19: well-known drugs, new opportunities A.Kh. Ashirmetov, I.R. Mavlyanov, Z.I. Mavlyanov, G.Zh. Zharylkasynova
47 [GO] Health Risk Analysis 2021―Jan―05 Dependence between mortality in regions and prevalence of active SARS-COV2 carriers and resources available to public healthcare organizations V.S. Stepanov
48 [GO] Health Risk Analysis 2020―Dec―03 Understanding the perception and hierarchy of risks: an environmental medico-scientific perspective with COVID-19 in mind J. Reis, N.V. Zaitseva, P.S. Spencer
49 [GO] Health Risk Analysis 2020―Oct―16 Understanding the perception and hierarchy of risks: an environmental medico-scientific perspective with COVID-19 in mind J. Reis, N.V. Zaitseva, P.S. Spencer
50 [GO] Health Risk Analysis 2020―Aug―10 Dynamics of local epidemic COVID-19 outbreak through the prism of compartment modeling V.F. Obesnyuk
51 [GO] Health Risk Analysis 2020―Jul―14 Dynamics of local epidemic COVID-19 outbreak through the prism of compartment modeling V.F. Obesnyuk
 [1] 

51 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec